Revasc (desirudin)
- Region
- 🇪🇺 EU
- Active substance
- desirudin
- Company
- Canyon Pharmaceuticals Ltd.
- Status
- Withdrawn
- Therapeutic area
- Venous Thrombosis
- EU approval
- Wed 09 Jul 1997
- Application
- EMEA/H/C/000104
- ATC
- B01AE01
- Official record
- www.ema.europa.eu
Indication
Prevention of deep venous thrombosis in patients undergoing elective hip or knee replacement surgery.
Regulatory milestones
No milestones recorded in the last year.
Follow Revasc
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.